Showing 1,081 - 1,100 results of 2,284 for search '"Cardiovascular disease"', query time: 0.06s Refine Results
  1. 1081

    Comparison of Mean Platelet Volume (MPV) in Patients with Psoriasis and Healthy Individuals by Komal Shehzade, Saulat Zahra, Rabia Ishfaq, Kayinat Samreen, Maria Khalid, Fahad Usman

    Published 2025-01-01
    “…Exclusion criteria included recent surgery, obesity (BMI > 30), and cardiovascular disease. Participants were divided into psoriasis patients (n=31) and healthy controls (n=169). …”
    Get full text
    Article
  2. 1082

    Correlation of triglyceride glucose index with all cause mortality in acute myocardial infarction patients following percutaneous coronary intervention by Guang Yang, Zilun Huang, Shanjie Wang, Shuang Yang

    Published 2025-01-01
    “…Abstract The Triglyceride glucose (TyG) index is a dependable indicator of IR, with numerous studies underscoring its influence on Cardiovascular disease. Nevertheless, the connection between the TyG index and prognosis in AMI patients after PCI is still uncertain. …”
    Get full text
    Article
  3. 1083

    The weight-adjusted-waist index predicts all-cause and cardiovascular mortality in hypertension by Yu Zheng, Zixing Nie, Yifan Zhang, Tao Sun

    Published 2025-02-01
    “…As a continuous variable, WWI was linked to higher rates of mortality from all-cause (HR = 1.23, 95% CI = 1.14, 1.33) and cardiovascular disease (CVD) (HR = 1.43, 95% CI = 1.23, 1.66) with hypertension in Model 3 adjusted for variables. …”
    Get full text
    Article
  4. 1084

    Interplay of fatty acids, insulin and exercise in vascular health by Kara C. Anderson, Jia Liu, Zhenqi Liu

    Published 2025-01-01
    “…Abstract Fatty acid metabolism, exercise, and insulin action play critical roles in maintaining vascular health, especially relevant in metabolic disorders such as obesity, type 2 diabetes, and cardiovascular disease. Insulin, a vasoactive hormone, induces arterial vasodilation throughout the arterial tree, increasing arterial compliance and enhancing tissue perfusion. …”
    Get full text
    Article
  5. 1085

    Glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide agonists for the treatment of obesity and diabetes mellitus by Alexander C. Martins, Beatriz G. de la Torre, Fernando Albericio

    Published 2024-04-01
    “…Obesity is strongly linked to serious health conditions like cardiovascular disease and insulin resistance, leading to a cascade of health risks. …”
    Get full text
    Article
  6. 1086

    Analysis of periodontal status in Polish patients with rheumatoid arthritis treated with biological therapies by Joanna Samborska-Mazur, Dorota Sikorska, Marzena Liliana Wyganowska

    Published 2024-11-01
    “…Introduction Periodontitis, characterized by inflammation affecting the tooth-supporting tissues, may increase the risk of rheumatoid arthritis (RA) or cardiovascular diseases. The aim of the study was to evaluate the periodontal status in RA patients and its impact on the inflammatory markers and red cell parameters obtained from complete blood laboratory tests to study the risk of cardiovascular disease development. …”
    Get full text
    Article
  7. 1087

    Rosuvastatin effects on the HDL proteome in hyperlipidemic patients by Vavlukis Ana, Mladenovska Kristina, Davalieva Katarina, Vavlukis Marija, Dimovski Aleksandar

    Published 2023-09-01
    “…The focus of this study was to evaluate the HDL proteome in dyslipidemic subjects without an established cardiovascular disease, as well as to test whether rosuvastatin treatment alters the HDL proteome. …”
    Get full text
    Article
  8. 1088

    Positive self-perceived health of octogenarians participating in community groups by Rodrigo Krug, Ione Schneider, Susana Confortin, Danielle Antes, Maruí Giehl, Marize Lopes, André Xavier, Eleonora d'Orsi, Giovana Mazo

    Published 2017-03-01
    “…The factors associated with positive self-perceived health were as follows: to receive a monthly income higher than six minimum wages (PR=1.39; 95%CI=0.91-2.11), to smoke currently (PR=1.75; 95%CI=1.25-2.46), to be physically active during leisure time (PR=1.33; 95%CI=1.06-1.67), to have arthritis or rheumatism (PR=0.55; 95%CI=0.37-0.80), diabetes (PR=0.54; 95%CI=0.37-0.79) and cardiovascular disease (OR=0.71; 95%CI=0.53-0.95), apart from using medications (PR=0.74; 95%CI=0.60-0.91). …”
    Get full text
    Article
  9. 1089

    Reduced Cardiovascular Capacity and Resting Metabolic Rate in Men with Prostate Cancer Undergoing Androgen Deprivation: A Comprehensive Cross-Sectional Investigation by Bradley A. Wall, Daniel A. Galvão, Naeem Fatehee, Dennis R. Taaffe, Nigel Spry, David Joseph, Robert U. Newton

    Published 2015-01-01
    “…To investigate if androgen deprivation therapy exposure is associated with additional risk factors for cardiovascular disease and metabolic treatment-related toxicities. …”
    Get full text
    Article
  10. 1090

    Smoking as a causative factor in chronic kidney disease: a two-sample Mendelian randomization study by Yue Yang, Zheng Zhang, Hai-tao Lu, Qian-qian Xu, Li Zhuo, Wen-ge Li

    Published 2025-12-01
    “…Additionally, the effect of smoking on CKD was mediated by factors such as body mass index, cardiovascular disease, hypertension, and type 2 diabetes. …”
    Get full text
    Article
  11. 1091

    Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: where do we stand and what may be the future? by Beatrice Maranini, Roberta Foti, Moustapha Taha, Veronica Venturelli, Andrea Lo Monaco, Marcello Govoni

    Published 2025-01-01
    “…Over the past few years, Janus kinase inhibitors (JAKis) have been reported to have promising efficacy in the treatment of active RA, but recent concerns have been raised about their safety profile, namely malignancy and cardiovascular disease, limiting their use to certain patient categories. …”
    Get full text
    Article
  12. 1092

    Pleiotropic effects of niacin: Current possibilities for its clinical use by Zeman Miroslav, Vecka Marek, Perlík František, Staňková Barbora, Hromádka Robert, Tvrzická Eva, Širc Jakub, Hrib Jakub, Žák Aleš

    Published 2016-12-01
    “…Niacin was the first hypolipidemic drug to significantly reduce both major cardiovascular events and mortality in patients with cardiovascular disease. Niacin favorably influences all lipoprotein classes, including lipoprotein[a],and belongs to the most potent hypolipidemic drugs for increasing HDL-C. …”
    Get full text
    Article
  13. 1093
  14. 1094
  15. 1095

    Plasma and Red Cell Reference Intervals of 5-Methyltetrahydrofolate of Healthy Adults in Whom Biochemical Functional Deficiencies of Folate and Vitamin B12 Had Been Excluded by Agata Sobczyńska-Malefora, Dominic J. Harrington, Kieran Voong, Martin J. Shearer

    Published 2014-01-01
    “…There is evidence that suboptimal 5-MTHF availability is a risk factor for cardiovascular disease independent of homocysteine. The analysis of folates remains challenging and is almost exclusively limited to the reporting of “total” folate rather than individual molecular forms. …”
    Get full text
    Article
  16. 1096

    Understanding the Activation of Platelets in Diabetes and Its Modulation by Allyl Methyl Sulfide, an Active Metabolite of Garlic by Navya Malladi, Ebin Johny, Shravan K. Uppulapu, Vikas Tiwari, Md Jahangir Alam, Ramu Adela, Sanjay K. Banerjee

    Published 2021-01-01
    “…Diabetes mellitus (DM) is a chronic metabolic disorder associated with higher risk of having cardiovascular disease. Platelets play a promising role in the pathogenesis of cardiovascular complications in diabetes. …”
    Get full text
    Article
  17. 1097

    Systematic review of exercise for the treatment of pediatric metabolic dysfunction-associated steatotic liver disease. by Martha R Smith, Elizabeth L Yu, Ghattas J Malki, Kimberly P Newton, Nidhi P Goyal, Karen M Heskett, Jeffrey B Schwimmer

    Published 2024-01-01
    “…<h4>Background & aims</h4>Steatotic liver disease affects approximately 1 in 10 children in the U.S. and increases the risk of cirrhosis, diabetes, and cardiovascular disease. Lifestyle modification centered on increased physical activity and dietary improvement is the primary management approach. …”
    Get full text
    Article
  18. 1098

    Self-management of non-communicable diseases in low- and middle-income countries: A scoping review. by Jason Hearn, Isaac Ssinabulya, Jeremy I Schwartz, Ann R Akiteng, Heather J Ross, Joseph A Cafazzo

    Published 2019-01-01
    “…Furthermore, the results indicate a need for further research into the self-management of cardiovascular diseases, as well as for the co-management of diabetes and cardiovascular disease.…”
    Get full text
    Article
  19. 1099

    Antiproliferative effect of hydroalcoholic brown propolis extract on tumor and non-tumor cells by I. Vendruscolo, G. H. Berton, M. T. Biffi, P. A. Bressiani, A. K. G. Oliveira, A. P. Berti, V. M. Concato-Lopes, W. R. Pavanelli, A. P. Simon, T. L. C. Oldoni, F. A. R. Santos, I. A. L. Dalmolin, M. H. G. Canteri, E. Düsman

    Published 2025-01-01
    “…Abstract Studies show that propolis has antimicrobial, antifungal, antiviral, anti-inflammatory, antioxidant, antitumor, and immunomodulatory properties, and may protect against diseases such as diabetes, cardiovascular disease, and cancer. We aimed to extract compounds of brown propolis with hydroalcoholic solvents and evaluate their cytotoxic activity on tumor and non-tumor cells by MTT test. …”
    Get full text
    Article
  20. 1100

    Racial/ethnic differences in the associations between social support and cardiovascular morbidity and mortality in the Multi-Ethnic Study of Atherosclerosis (MESA) by Jeanean B. Naqvi, Taynara Formagini, Matthew A. Allison, Namratha R. Kandula, Jee Won Park, Britta A. Larsen

    Published 2025-01-01
    “…Abstract Background Despite the established link between social support and cardiovascular disease (CVD) outcomes, few studies have examined racial/ethnic variation in these associations. …”
    Get full text
    Article